Search results for "Education"
Spotlight on diabetes and chronic kidney disease
A study showed that chronic kidney disease has declined among U.S. adults with diabetes. A meta-analysis found that sodium-glucose cotransporter-2 inhibitors prevented kidney decline similarly in those with and without diabetes. A survey identified knowledge gaps among prescribers on this topic.
https://diabetes.acponline.org/archives/2022/11/11/5.htm
11 Nov 2022
Social, medical intervention improved glycemic control in rural patients with diabetes
A population health team assessed patients' medical, behavioral, and social needs with annual health risk assessments and partnered with community organizations to improve their access to food, transportation, and medicine.
https://diabetes.acponline.org/archives/2023/03/10/3.htm
10 Mar 2023
Spotlight on exercise
Sports medicine experts updated their recommendations on exercise in type 2 diabetes, while a study found that physical activity was associated with lower dementia risk in patients with new type 2 diabetes, and another found that exercise might be more beneficial in the afternoon than the morning.
https://diabetes.acponline.org/archives/2022/03/11/5.htm
11 Mar 2022
Spotlight on diabetes incidence in the pandemic
Two studies tried to determine whether COVID-19 infection leads to a subsequent increase in the risk of developing diabetes, while another highlighted how type 2 diabetes has risen among youth since the start of the pandemic.
https://diabetes.acponline.org/archives/2023/02/10/5.htm
10 Feb 2023
Spotlight on prescribing patterns
One study found that physicians were unlikely to deprescribe hypoglycemia-causing medications in older diabetes patients, while others found suboptimal use of glucagon-like peptide-1 receptor agonists, sodium-glucose cotransporter-2 inhibitors, and additional recommended medications.
https://diabetes.acponline.org/archives/2023/03/10/5.htm
10 Mar 2023
Avoiding hypoglycemia most compelling reason for deintensifying diabetes meds
Researchers presented older adults with type 2 diabetes with three scenarios in which deintensification may be indicated—poor health, limited life expectancy, and high hypoglycemia risk—and found that 8%, 4%, and 75%, respectively, viewed deintensification positively.
https://diabetes.acponline.org/archives/2022/10/14/3.htm
14 Oct 2022
Unrecognized risk factors for severe hypoglycemia outlined in insulin-treated type 2 diabetes
An industry-funded case-control study of data from a U.S. administrative claims database found that pregnancy, alcohol misuse, short or rapid-acting insulin, and smoking, among other conditions and medications, were independently associated with increased risk.
https://diabetes.acponline.org/archives/2022/04/08/3.htm
8 Apr 2022
Initiation of glucose-lowering therapies may be associated with reduced physical activity
An analysis of 148 participants from three randomized trials found that starting liraglutide, empagliflozin, or sitagliptin was associated with reduction in physical activity of about 1,000 steps per day or 10 minutes of moderate to vigorous physical activity per day.
https://diabetes.acponline.org/archives/2022/09/16/2.htm
16 Sep 2022
Glucose-lowering treatment after type 2 diabetes diagnosis differed by race/ethnicity
Among 77,199 patients in a U.S. health system with a new diagnosis of diabetes from 2005 to 2016, 47% started a diabetes medication within 12 months. Prevalence differed by race and ethnicity, although the difference was mitigated by variation in HbA1c levels.
https://diabetes.acponline.org/archives/2022/08/12/3.htm
12 Aug 2022
Spotlight on inpatient hyperglycemia
A new guideline offered recommendations on managing hyperglycemia in hospital patients with or without diabetes. Recent studies looked at the effects of elevated blood glucose levels after surgery and in the ICU.
https://diabetes.acponline.org/archives/2022/07/08/5.htm
8 Jul 2022